Vaccine, Salk: Vaccine against poliomyelitis named for Dr. Jonas Salk who developed and introduced it in 1955. It was the first type of polio vaccine to become available. It was made by cultivating three strains of the virus separately in monkey tissue. The virus was separated from the tissue, stored for a week, and killed with formaldehyde. This killed-virus vaccine was given by injection and required 4 "shots." The oral form of the vaccine, subsequently developed by Dr. Albert Sabin, is in standard use today since it is easier to administer and is more effective than the Salk vaccine. The Salk vaccine is now exclusively of historic interest.
The American physician and virologist Jonas Salk (1914-1995) did research on the influenza virus at the University of Michigan and on poliovirus at the University of Pittsburgh. In 1963 he became the first director of the Salk Institute for Biological Studies at the University of California, San Diego.
Jonas Salk Biography. Developer of Polio Vaccine Jonas Salk Date of birth: October 28, 1914 Date of death: June 23, 1995. Print Biography
Salk produces polio vaccine 1952. Poliomyelitis has been around since ancient times. There is still no cure for the disease. But at the peak of its devastation in the United ...
Introduction | History | Vaccines | Field Trial | Postscript | Resources and References. Introduction. The Salk polio vaccine field trials constitute one of the most ...
Salk needed to find a way to process the viruses so that they were less infectious, before using them in a vaccine. In 1952, Salk was the first to develop a successful ...
noun a vaccine that contains three types of inactivated poliomyelitis viruses and induces immunity against the disease. Origin: 1950–55; named after J. E. Salk :10 ...